Rohto Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Rohto Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Rohto Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Rohto Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) manufactures and markets pharmaceutical products, cosmetics, and functional foods. The company offers products for eye care, skin care, internal medicine and other diseases. Under eyecare products, the company offers eye drops, contact lenses and eyewash. Under skincare products, the company offers face wash, creams, lotions, medicine and medicated products. It also offers medicines for internal use such as digestive products and herbal medicines. It has manufacturing and research laboratories in Iga, Osaka and Kyoto. The company along with its subsidiaries operates across the Americas, Asia, Japan, Oceania, Africa, and Europe. Rohto Pharmaceutical is headquartered in Osaka, Japan.
Headquarters
Japan
Address
1-8-1, Tatsumi-Nishi, Ikuno-Ku, Osaka-Shi, 544-8666
Website
www.rohto.co.jp
Telephone
81 6 67581231
No of Employees
9,144
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4527 (TYO)
Revenue (2025)
$2.0B
14%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
0.2%
(2025 vs 2024)
Market Cap*
$3.6B
Net Profit Margin (2025)
XYZ
-12.0%
(2025 vs 2024)
* As of and is in US$
Rohto Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Eye Care | Service: | Auna |
| Eye Drops | CDMO | Skio |
| Eye Wash Preparations | Skin Aqua | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In October, the company, Haleon Japan, and Milbon collaborated with Toyo Warehouse Co. to enhance logistics efficiency and build a sustainable supply chain. |
| 2025 | New Products/Services | In September, the company announced the launch of Proly Repair Color Treatment, a color treatment from its hair care brand Proly. |
| 2025 | Contracts/Agreements | In September, the company entered into an agreement with Tokyo University of Science to establish collaborative research center for cyber-physical systems. |
Competitor Comparison
| Key Parameters | Rohto Pharmaceutical Co Ltd | Daiichi Sankyo Co Ltd | Otsuka Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | Shionogi & Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Osaka-Shi | Chuo-Ku | Chiyoda-Ku | Chuo-Ku | Osaka |
| State/Province | Osaka | Tokyo | Tokyo | Tokyo | Osaka |
| No. of Employees | 9,144 | 19,765 | 6,070 | 7,872 | 4,959 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kunio Yamada | Chairman | Executive Board | 2019 | - |
| Noriko Suenobu | Director; Chief Research Officer | Executive Board | 2025 | - |
| Yasunori Kawasaki | Chief Human Resources Officer; Director | Executive Board | 2023 | - |
| Masae Yamanaka | Chief Transformation Officer; Director | Executive Board | 2024 | - |
| Hidetoshi Segi | Chief Executive Officer; President | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer